Osteo Formula
Natural health product licensed in Canada
- Other names
- Osteo
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80041902
- Status
- Active licence
- Licence date
- 24 April 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Iode: up to 498 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 150 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 199.8 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 9.9 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3',4',5,7-Pentahydroxyflavone Source : Styphnolobium japonicum - Bourgeon floral | 8 mg | Not calculated |
| Iode Source : Ascophyllum nodosum - whole | 83 mcg | 498 µg |
| Cuivre Source : Gluconate cuivrique | 333.3 mcg | 1999.8 µg |
| Vitamine C Source : Ascorbate de calcium | 33.3 mg | 199,800 µg |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 105 mg Potency : 4 mg Curcuminoids | 4.2 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 1.65 mcg | 9.9 µg |
| Vitamine D Source : Cholécalciférol | 66.7 UI | 10.005 µg |
| Boswellia serrata Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 7:1 Dry plant equivalent : 46.2 mg Potency : 60 % Boswellic acids | 6.6 mg | Not calculated |
| Silicium Source : Equisetum arvense | 1.6 mg | Not calculated |
| Silicium Source : Plante | 1.6 mg | Not calculated |
Non-medicinal ingredients
NA, Eau purifiée, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Capsule | 1 day |
Uses authorised in Canada
Helps in the development and maintenance of bones and teeth. Calcium intake when combined with sufficient vitamin D, a healthy diet, and regular exercise may reduce the risk of developing osteoporosis. A factor in the maintenance of good health. Helps the body to metabolize fats, carbohydrates and proteins. Helps in the development of cartilage and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps in the absorption of calcium and phosphorus. Helps to form red blood cells. Helps in the function of the thyroid gland.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a physician prior to use if you are pregnant or breastfeeding, if you have a history of gallstones, biliary tract obstructions and/or stomach ulcers, or if you are taking blood thinners.
Source
Official Health Canada record, licence 80041902
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.